Literature DB >> 21455597

Matrix metalloproteinase-9 is associated with relapse and prognosis of patients with colorectal cancer.

Dake Chu1, Zhengwei Zhao, Yi Zhou, Yunming Li, Jipeng Li, Jianyong Zheng, Qingchuan Zhao, Weizhong Wang.   

Abstract

BACKGROUND: Matrix metalloproteinase-9 is a member of the MMP family, which is overexpressed in some solid tumors and is thought to enhance tumor invasion and metastasis ability. The present study aims to examine MMP-9 expression in human colorectal cancer and to determine its association with clinicopathological characteristics and prognosis.
METHODS: Colorectal cancer and adjacent normal tissues from 192 patients were investigated by immunohistochemical assay. Staining evaluation results were analyzed statistically in relation to various clinicopathological characters, disease-free survival, and overall survival.
RESULTS: High level of MMP-9 expression was detected in colorectal cancer, significantly more than in normal colorectal epithelial cells. In colorectal cancer, MMP-9 was significantly positively correlated with depth of invasion, lymph node metastasis, and distant metastasis. However, no correlations between MMP-9 expression and patient age, sex, tumor location or differentiation status were detected. Disease-free and overall survival were significantly poorer for patients with positive MMP-9 staining than for those with MMP-9-negative tumors.
CONCLUSIONS: Our findings emphasize the important role of MMP-9 in the invasion and metastasis process in human colorectal cancer. It could also serve as a novel prognostic marker that is independent of, and additive to, the tumor-node-metastasis (TNM) staging system.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21455597     DOI: 10.1245/s10434-011-1686-3

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  27 in total

1.  MMP-9 polymorphisms are related to serum lipids levels but not associated with colorectal cancer susceptibility in Chinese population.

Authors:  Zhi-Hui Yang; Shi-Ning Li; Jin-Xing Liu; Qing-Xi Guo; Xing-Wang Sun
Journal:  Mol Biol Rep       Date:  2012-06-24       Impact factor: 2.316

2.  Expression profile of NF-κB regulated genes in sporadic colorectal cancer patients.

Authors:  Betsy Annel González-Quezada; Uriel Francisco Santana-Bejarano; Alfredo Corona-Rivera; Helia Judith Pimentel-Gutiérrez; Rocío Silva-Cruz; Citlalli Ortega-De-la-Torre; Ramón Franco-Topete; Karina Franco-Topete; Manuel Willebaldo Centeno-Flores; Víctor Manuel Maciel-Gutiérrez; Jorge Román Corona-Rivera; Juan Armendáriz-Borunda; Lucina Bobadilla-Morales
Journal:  Oncol Lett       Date:  2018-03-07       Impact factor: 2.967

3.  Toll-Like Receptor 4 and Matrix Metalloproteases 11 and 13 as Predictors of Tumor Recurrence and Survival in Stage II Colorectal Cancer.

Authors:  Noemi Eiro; Juan Francisco Carrión; Sandra Cid; Alejandro Andicoechea; José Luis García-Muñiz; Luis O González; Francisco J Vizoso
Journal:  Pathol Oncol Res       Date:  2019-02-01       Impact factor: 3.201

4.  High co-expression of vascular endothelial growth factor receptor-1 and Snail is associated with poor prognosis after curative resection of hepatocellular carcinoma.

Authors:  Tao Li; Yuhua Zhu; Wanhua Ren; Shifeng Xu; Zhen Yang; Aiju Fang; Chengyong Qin
Journal:  Med Oncol       Date:  2012-01-15       Impact factor: 3.064

5.  Co-delivery of curcumin and doxorubicin in PEGylated liposomes favored the antineoplastic C26 murine colon carcinoma microenvironment.

Authors:  Alina Sesarman; Lucia Tefas; Bianca Sylvester; Emilia Licarete; Valentin Rauca; Lavinia Luput; Laura Patras; Sebastian Porav; Manuela Banciu; Alina Porfire
Journal:  Drug Deliv Transl Res       Date:  2019-02       Impact factor: 4.617

6.  Matrilysin-2 expression in colorectal cancer is associated with overall survival of patients.

Authors:  Qinglin Hu; Chuanjing Yan; Chengfei Xu; Hai Yan; Lian Qing; Yanjun Pu; Zeyou He; Xiaojun Li
Journal:  Tumour Biol       Date:  2013-12-08

7.  Effect of the expression of matrix metalloproteases and their tissue inhibitors on survival of patients with resectable colorectal cancer.

Authors:  Lucía González; Noemí Eiró; Luis O González; Alejandro Andicoechea; Esther Barbón; José L García-Muñiz; Francisco J Vizoso
Journal:  Dig Dis Sci       Date:  2012-04-10       Impact factor: 3.199

8.  APRIL induces tumorigenesis and metastasis of colorectal cancer cells via activation of the PI3K/Akt pathway.

Authors:  Guihua Wang; Feng Wang; Weifeng Ding; Jingchun Wang; Rongrong Jing; Haiquan Li; Xudong Wang; Yueguo Wang; Shaoqing Ju; Huimin Wang
Journal:  PLoS One       Date:  2013-01-29       Impact factor: 3.240

9.  Matrix metalloproteinase-9: a deleterious link between hepatic ischemia-reperfusion and colorectal cancer.

Authors:  Sébastien Lenglet; François Mach; Fabrizio Montecucco
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

10.  Matrix metalloproteinase 9 expression and prognosis in colorectal cancer: a meta-analysis.

Authors:  Chun-Yu Li; Peng Yuan; Shu-Sen Lin; Cheng-Fei Song; Wei-Yu Guan; Lu Yuan; Rong-Bin Lai; Ying Gao; Yan Wang
Journal:  Tumour Biol       Date:  2012-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.